Roche partners on epigenomic analysis; Microsoft strikes mHealth deal;

> Roche ($RHHBY) partnered with the Garvan Institute to develop targeted epigenomic analysis technologies. News

> Microsoft ($MSFT) struck a deal with TracFone to run a mHealth pilot project in diabetes patients. Item

> FDA officials discussed their stance on approval of NGS assays. Feature

> OmniComm Systems reported record contract growth in the first half of the year. Release

> Seven Bridges provided an update on its open-source, cloud-based workflow for cancer genomics. Article

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.